Paul Tudor Jones II's position in Medpace Holdings is currently worth $11.5M. That's 0.09% of their equity portfolio (299th largest holding). The first Medpace Holdings trade was made in Q3 2016. Since then Paul Tudor Jones II bought shares nineteen more times and sold shares on 21 occasions. The stake costed the investor $7.15M, netting the investor a gain of 61% so far.
Disclosed in a recent SEC filing, Cornelius P. McCarthy III , Director at Medpace Hldgs (NASDAQ: MEDP ), made a strategic move by acquiring company stock opt...
According to a new report published by Allied Market Research, titled, Oncology Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV),...